Europe Brain Cancer Diagnostics Market to Grow at a CAGR of 16.4% to reach US$ 601.0 million by 2028 Million from 2021 to 2028

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Europe Brain Cancer Diagnostics Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Europe Brain Cancer Diagnostics Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1
5.1.2 Rising incidence of brain tumors.
5.1.3 Advancements in diagnostic imaging technologies.
5.1.4 Growing awareness of early detection benefits.

5.2 Market Opportunities

5.2.1
5.2.2 Development of liquid biopsy tests.
5.2.3 Collaborations with research institutions.
5.2.4 Expansion of diagnostic services in hospitals

5.3 Future Trends

5.3.1
5.3.2 Increased use of AI in diagnostics.
5.3.3 Growth in precision medicine approaches.
5.3.4 Focus on non-invasive diagnostic methods.

5.4 Impact of Drivers and Restraints

6. Europe Brain Cancer Diagnostics Market Regional Analysis

6.1 Europe Brain Cancer Diagnostics Market Overview

6.2 Europe Brain Cancer Diagnostics Market Revenue 2019-2028 (US$ Million)

6.3 Europe Brain Cancer Diagnostics Market Forecast Analysis

7. Europe Brain Cancer Diagnostics Market Analysis – by Diagnostic Type

7.1 Imaging Test

7.1.1 Overview
7.1.2 Imaging Test: Europe Brain Cancer Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Lumbar Puncture

7.2.1 Overview
7.2.2 Lumbar Puncture: Europe Brain Cancer Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Biopsy

7.3.1 Overview
7.3.2 Biopsy: Europe Brain Cancer Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

7.4 Molecular Testing

7.4.1 Overview
7.4.2 Molecular Testing: Europe Brain Cancer Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Brain Cancer Diagnostics Market Analysis – by Cancer Type

8.1 Acoustic Neuroma

8.1.1 Overview
8.1.2 Acoustic Neuroma: Europe Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.2 Astrocytoma

8.2.1 Overview
8.2.2 Astrocytoma: Europe Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.3 Craniopharyngiomas

8.3.1 Overview
8.3.2 Craniopharyngiomas: Europe Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Ganglioneuromas

8.4.1 Overview
8.4.2 Ganglioneuromas: Europe Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Glioblastoma Multiforme

8.5.1 Overview
8.5.2 Glioblastoma Multiforme: Europe Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Meningiomas

8.6.1 Overview
8.6.2 Meningiomas: Europe Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.7 Ependymomas

8.7.1 Overview
8.7.2 Ependymomas: Europe Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9. Europe Brain Cancer Diagnostics Market Analysis – by End User

9.1 Hospitals

9.1.1 Overview
9.1.2 Ependymomas: Europe Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.2 Specialty Clinics

9.2.1 Overview
9.2.2 Ependymomas: Europe Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.3 Ambulatory Surgical Centers

9.3.1 Overview
9.3.2 Ependymomas: Europe Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10. Europe Brain Cancer Diagnostics Market – Europe Analysis

10.1 Europe

10.1.1 Europe Brain Cancer Diagnostics Market Breakdown, by Key Country, 2022 and 2028 (%)
10.1.1.1 Europe Brain Cancer Diagnostics Market – Revenue and Forecast Analysis – by Country
10.1.1.1 UK: Europe Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 UK: Europe Brain Cancer Diagnostics Market Breakdown, by Diagnostic Type
10.1.1.1.2 UK: Europe Brain Cancer Diagnostics Market Breakdown, by Cancer Type
10.1.1.1.3 UK: Europe Brain Cancer Diagnostics Market Breakdown, by End User

10.1.1.2 Germany: Europe Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 Germany: Europe Brain Cancer Diagnostics Market Breakdown, by Diagnostic Type
10.1.1.2.2 Germany: Europe Brain Cancer Diagnostics Market Breakdown, by Cancer Type
10.1.1.2.3 Germany: Europe Brain Cancer Diagnostics Market Breakdown, by End User

10.1.1.3 France: Europe Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 France: Europe Brain Cancer Diagnostics Market Breakdown, by Diagnostic Type
10.1.1.3.2 France: Europe Brain Cancer Diagnostics Market Breakdown, by Cancer Type
10.1.1.3.3 France: Europe Brain Cancer Diagnostics Market Breakdown, by End User

10.1.1.4 Russia: Europe Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1 Russia: Europe Brain Cancer Diagnostics Market Breakdown, by Diagnostic Type
10.1.1.4.2 Russia: Europe Brain Cancer Diagnostics Market Breakdown, by Cancer Type
10.1.1.4.3 Russia: Europe Brain Cancer Diagnostics Market Breakdown, by End User

10.1.1.5 Italy: Europe Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.1 Italy: Europe Brain Cancer Diagnostics Market Breakdown, by Diagnostic Type
10.1.1.5.2 Italy: Europe Brain Cancer Diagnostics Market Breakdown, by Cancer Type
10.1.1.5.3 Italy: Europe Brain Cancer Diagnostics Market Breakdown, by End User

10.1.1.6 Rest of Europe: Europe Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.1 Rest of Europe: Europe Brain Cancer Diagnostics Market Breakdown, by Diagnostic Type
10.1.1.6.2 Rest of Europe: Europe Brain Cancer Diagnostics Market Breakdown, by Cancer Type
10.1.1.6.3 Rest of Europe: Europe Brain Cancer Diagnostics Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Europe Brain Cancer Diagnostics Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Thermo Fisher Scientific Inc.

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Siemens Healthineers A

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 GE Healthcare

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Biocept, Inc.

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Koninklijke Philips N.V

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Canon Medical Systems

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Hitachi, Ltd.

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Neusoft Medical Systems

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

14. Appendix

14.1 About Business Market Insights